AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Wainua (eplontersen) — Worldwide product sales by Year
Wainua (eplontersen) — Worldwide product sales ($M) ($M)
AstraZeneca Wainua (eplontersen) — Worldwide product sales: $212M in FY2025, up 149.4% from a year earlier.
Where the FY2025 figure comes from
“|| Wainua | 212 | n/m | n/m | 204 | n/m | 4 | n/m | n/m | 4 | n/m | n/m | - | - | -”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Wainua (eplontersen) — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 212 | +149.4% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 85 | – | Form 6-K FY2024Q4 Earnings Release ↗ |
Breakdown
What makes up wainua (eplontersen) — Worldwide product sales
- Wainua (eplontersen) — Worldwide YoY actual (%)–
- Wainua (eplontersen) — Worldwide YoY CER (%)–
- Wainua (eplontersen) — US product sales ($M)204 · FY2025
- Wainua (eplontersen) — Emerging Markets product sales ($M)4 · FY2025
- Wainua (eplontersen) — Europe product sales ($M)4 · FY2025
- Wainua (eplontersen) — Established RoW product sales ($M)0 · FY2025
Cite this data
StockData. (2026). AstraZeneca Wainua (eplontersen) — Worldwide product sales ($M), annual FY2024–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-wainua-world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.